Randomized Phase II Trial of Paclitaxel, Carboplatin and rhuMAb Her-2 [trastuzumab] (Herceptin) as First-Line Chemotherapy in Patients With Metastatic Breast Cancer Who Overexpress Her-2
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Paclitaxel; Trastuzumab
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 08 Oct 2019 Biomarkers information updated
- 26 Sep 2005 New trial record.